TIGERMED(03347.HK)

Event Tracking

Apr1

Taigemed Participates in Global MNC's Early Clinical Research Strategy Formulation

08:20

Mar30

Hangzhou 泰格 MedicinePlans to Invest 2 Billion YUAN in Low-Risk Wealth Management Products

12:41

TIGERMED released FY2025 Q4 earnings on March 30 After-Market (BJT), actual revenue HKD 2.009 B (forecast HKD 2.041 B), actual EPS HKD -0.1732 (forecast HKD 0.6312)

11:00

TIGERMED released FY2025 annual earnings on March 30 After-Market (BJT), actual revenue HKD 7.468 B (forecast HKD 7.728 B), actual EPS HKD 1.1338 (forecast HKD 1.5538)

11:00

Tigermed Announces Revenue and Profit Growth and Plans to Sell Rights to Lixin Medical

10:27

Hangzhou 泰格医药 Reports 2025 Fiscal Year Net Profit Doubling and Acquiring CRO Micron

08:35